Karolina Skagen1, Kjersti Johnsrud2, Kristin Evensen1, Helge Scott3, Kirsten Krohg-Sørensen4, Frode Reier-Nilsen5, Mona-Elisabeth Revheim6, Jan Gunnar Fjeld7, Mona Skjelland1, David Russell1. 1. Department of Neurology, Oslo University Hospital and University of Oslo, Oslo, Norway. 2. Department of Radiology and Nuclear Medicine, Oslo University Hospital and University of Oslo, Oslo, Norway. 3. Department of Pathology, Oslo University Hospital and University of Oslo, Oslo, Norway. 4. Department of Thoracic Surgery, Oslo University Hospital and University of Oslo, Oslo, Norway. 5. Department of Vascular and Thoracic surgery, Akershus University Hospital, Oslo, Norway. 6. Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. 7. Department of Radiology and Nuclear Medicine, Oslo University Hospital and Akershus University College of Applied Sciences, Oslo, Norway.
Abstract
BACKGROUND: Carotid artery plaque inflammation is thought to be an important marker of plaque vulnerability and increased stroke risk. AIM: The main aim of this study was to assess the level of agreement between 2-deoxy-2-[(18)F] fluoro-D-glucose (18F-FDG) uptake on PET (positron emission tomography) scan in carotid plaques, with cerebrovascular symptoms, carotid plaque ultrasound echogenicity and histological assessments of plaque inflammation. METHODS: Thirty-six patients with ≥70% carotid stenosis scheduled for carotid endarterectomy underwent a Colour Duplex ultrasound, (18)F-FDG PET/CT and blood tests less than 24 h prior to surgery. Plaques were defined as symptomatic when associated with ipsilateral cerebral ischemic symptoms within 30 days prior to inclusion. Plaques were assessed histologically following endarterectomy. The level of agreement between (18)F-FDG uptake (mean SUVmax and SUVmax ), and target-to-background ratio, symptoms, plaque echolucency, and histological evidence of inflammation was assessed. RESULTS: The amount of (18)F-FDG uptake in plaques and the amount of inflammation on histological assessment were significantly correlated (r = 0·521, P = 0·003). (18)F-FDG uptake was significantly higher in symptomatic plaques with median SUVmax 1·75 (1·26-2·04) in symptomatic, and 1·43 (1·15-2·28) in asymptomatic patients (P = 0·03). (18)F-FDG uptake was also positively correlated with echolucency on Doppler ultrasound (P = 0·03). CONCLUSION: (18)F-FDG uptake on PET/CT correlated with histological assessments of inflammation and was higher in patients with symptomatic compared with asymptomatic carotid artery plaques. These results support the use of (18)F-FDG PET/CT in the detection inflammation in carotid atherosclerosis, which may be of help in the detection of vulnerable plaques.
BACKGROUND: Carotid artery plaque inflammation is thought to be an important marker of plaque vulnerability and increased stroke risk. AIM: The main aim of this study was to assess the level of agreement between 2-deoxy-2-[(18)F] fluoro-D-glucose (18F-FDG) uptake on PET (positron emission tomography) scan in carotid plaques, with cerebrovascular symptoms, carotid plaque ultrasound echogenicity and histological assessments of plaque inflammation. METHODS: Thirty-six patients with ≥70% carotid stenosis scheduled for carotid endarterectomy underwent a Colour Duplex ultrasound, (18)F-FDG PET/CT and blood tests less than 24 h prior to surgery. Plaques were defined as symptomatic when associated with ipsilateral cerebral ischemic symptoms within 30 days prior to inclusion. Plaques were assessed histologically following endarterectomy. The level of agreement between (18)F-FDG uptake (mean SUVmax and SUVmax ), and target-to-background ratio, symptoms, plaque echolucency, and histological evidence of inflammation was assessed. RESULTS: The amount of (18)F-FDG uptake in plaques and the amount of inflammation on histological assessment were significantly correlated (r = 0·521, P = 0·003). (18)F-FDG uptake was significantly higher in symptomatic plaques with median SUVmax 1·75 (1·26-2·04) in symptomatic, and 1·43 (1·15-2·28) in asymptomatic patients (P = 0·03). (18)F-FDG uptake was also positively correlated with echolucency on Doppler ultrasound (P = 0·03). CONCLUSION: (18)F-FDG uptake on PET/CT correlated with histological assessments of inflammation and was higher in patients with symptomatic compared with asymptomatic carotid artery plaques. These results support the use of (18)F-FDG PET/CT in the detection inflammation in carotid atherosclerosis, which may be of help in the detection of vulnerable plaques.
Authors: Carlo De Dominicis; Paola Perrotta; Sergio Dall'Angelo; Leonie Wyffels; Steven Staelens; G R Y De Meyer; Matteo Zanda Journal: ACS Med Chem Lett Date: 2020-02-19 Impact factor: 4.345
Authors: Antonio Maria Sammartino; Raffaele Falco; Andrea Drera; Francesco Dondi; Pietro Bellini; Francesco Bertagna; Enrico Vizzardi Journal: Int J Cardiovasc Imaging Date: 2022-10-18 Impact factor: 2.316
Authors: Nicholas R Evans; Jason M Tarkin; Mohammed M Chowdhury; Elizabeth A Warburton; James H F Rudd Journal: Curr Atheroscler Rep Date: 2016-06 Impact factor: 5.113
Authors: Charlotte D C C van der Heijden; Rob Ter Horst; Inge C L van den Munckhof; Kiki Schraa; Jacqueline de Graaf; Leo A B Joosten; A H Jan Danser; Mihai G Netea; Jaap Deinum; Joost Rutten; Niels P Riksen Journal: J Clin Endocrinol Metab Date: 2020-08-01 Impact factor: 5.958
Authors: Mohammed M Chowdhury; Jason M Tarkin; Nicholas R Evans; Elizabeth Le; Elizabeth A Warburton; Paul D Hayes; James H F Rudd; Patrick A Coughlin Journal: Eur J Vasc Endovasc Surg Date: 2018-05-02 Impact factor: 7.069